Form 4: SI-BONE Director Mika Nishimura Granted Restricted Stock Units Valued at $0.00

SI-BONE, Inc. Director Mika Nishimura was granted 8,675 restricted stock units (RSUs) on June 5, 2025, as part of her compensation, which will vest upon specific conditions.

Summary

• Mika Nishimura, a Director of SI-BONE, Inc. (SIBN), acquired 8,675 shares of common stock through the grant of restricted stock units (RSUs) on June 5, 2025.
• The transaction price for these RSUs was $0.00, as they represent a contingent right to receive shares upon vesting.
• Following this transaction, Mika Nishimura beneficially owns a total of 36,816 shares, which includes the newly granted 8,675 RSUs.
• Each restricted stock unit represents a contingent right to receive one share of SI-BONE's common stock.
• The 8,675 RSUs will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, contingent on Ms. Nishimura's continuous service as a member of the Board of Directors until such date.

Sentiment

Score: 6

Explanation: The document reports a routine equity compensation grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. There are no negative implications or significant new information beyond the compensation detail.

Positives

• The grant of restricted stock units to Director Mika Nishimura aligns her interests with those of the shareholders, as the value of her compensation is tied to the company's stock performance.
• This RSU grant is a standard form of non-cash compensation for directors, indicating ongoing commitment and retention of key board members.

Future Outlook

The 8,675 restricted stock units granted to Director Mika Nishimura are expected to vest 100% upon the earlier of the next annual general meeting of stockholders or one year from the Vesting Commencement Date, provided she continues her service on the Board of Directors.

Management Comments

• The Form 4 was signed by Michael Pisetsky, Attorney-in-Fact for Mika Nishimura, indicating the transaction was processed under a pre-existing power of attorney.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically the grant of equity compensation to a director. Such grants are common practice across various industries, including the medical device sector where SI-BONE operates, to incentivize and retain board members.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Mika Nishimura, a director of SI-BONE, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant of RSUs may result in minor future dilution upon vesting but is intended to align director incentives with shareholder interests.
• Employees: No direct impact on general employees mentioned in this filing.
• Director (Mika Nishimura): Receives equity compensation, increasing her beneficial ownership and aligning her financial interests with the company's performance.

Next Steps

• The restricted stock units are subject to vesting, which will occur upon the earlier of the next annual general meeting or one year from the Vesting Commencement Date, contingent on continuous service.

Key Dates

Keywords

SI-BONE, SIBN, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership, Corporate Governance